Titre The Chronic Myeloid Leukemia (CML) Registry of the GQR-LMC
Protocole ID MP-HMR-09-001
ClinicalTrials.gov ID
Type(s) de cancer Leucémie myéloïde chronique (LMC)
Phase Autres
Institution CISSS DE LAVAL
      1755 boul. René-Laennec, Laval, QC, H7M 3L9
Ville Laval
Investigateur(trice) principal(e) Dre Danielle Talbot
Coordonnateur(trice) Solange Tremblay
450-668-1010 poste 23603
Statut Actif en recrutement
Critètes d'éligibilité All patients in Canada who meet the following inclusion criteria may be enrolled in the CML
  • have a clinical diagnosis of CML;
  • are 18 years of age or older;
  • are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
Critètes d'exclusion Patients who meet any of the following criteria will be excluded from participation:
  • unwilling or unable to give written, informed consent;
  • under 18 years of age;
  • life expectancy of 3 months for a condition not related to CML